H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
H1N1 vaccine: Discussions and debates

H1N1 vaccine: Discussions and debates

U.S. clinical trials show single dose of H1N1 vaccine protects pregnant women, children under 10 need two doses

U.S. clinical trials show single dose of H1N1 vaccine protects pregnant women, children under 10 need two doses

Department of Health: CDC has allocated 964,100 doses of H1N1 vaccine to Pennsylvania to date

Department of Health: CDC has allocated 964,100 doses of H1N1 vaccine to Pennsylvania to date

Aetna provides free electronic roster billing to pharmacies and other providers for H1N1 flu vaccine claims

Aetna provides free electronic roster billing to pharmacies and other providers for H1N1 flu vaccine claims

Specimen Collection Kit to help medical personnel combat H1N1 and RSV

Specimen Collection Kit to help medical personnel combat H1N1 and RSV

Hetero bags 4 million dollar contract from Hard to Treat Diseases

Hetero bags 4 million dollar contract from Hard to Treat Diseases

Puricore reports increase in sales of 25% in Q3

Puricore reports increase in sales of 25% in Q3

Medco Health Solutions reports third-quarter total net revenues of $14.8 billion

Medco Health Solutions reports third-quarter total net revenues of $14.8 billion

West Pharmaceutical Services reports financial results for the third quarter of 2009

West Pharmaceutical Services reports financial results for the third quarter of 2009

Grand Brands launches Car Buddie hand sanitizer

Grand Brands launches Car Buddie hand sanitizer

Raycop's anti-bacterial vacuum cleaning system with UVC technology kills the H1N1 virus

Raycop's anti-bacterial vacuum cleaning system with UVC technology kills the H1N1 virus

Macomb County Health Department announces H1N1 influenza clinic

Macomb County Health Department announces H1N1 influenza clinic

Tamiflu in short supply, pharmacists compound doses for children suffering from the H1N1 flu virus

Tamiflu in short supply, pharmacists compound doses for children suffering from the H1N1 flu virus

Pregnant women tolerate the 2009 H1N1 flu vaccine, mount strong immune response

Pregnant women tolerate the 2009 H1N1 flu vaccine, mount strong immune response

FDA: Guidance document on diagnostic tests for the 2009 H1N1 influenza virus

FDA: Guidance document on diagnostic tests for the 2009 H1N1 influenza virus

Swine flu vaccine supply expected to increase 'in short order'

Swine flu vaccine supply expected to increase 'in short order'

Deaths from H1N1 rise by 700 in one week, WHO reports

Deaths from H1N1 rise by 700 in one week, WHO reports

A look at the odds associated with the influenza virus

A look at the odds associated with the influenza virus

The Clorox Company anounces fiscal 2010 first-quarter results

The Clorox Company anounces fiscal 2010 first-quarter results

Arrayit Corporation joins federal government in their efforts to help control health care costs

Arrayit Corporation joins federal government in their efforts to help control health care costs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.